Mary Akinola

Phase 3 Trial of Flutemetamol Labeled With Radioactive Fluorine 18 Imaging and Neuritic Plaque Density

Craig Curtis, José E. Gámez, Upinder Singh et al. · JAMA Neurology · 2015 · 329 citations · Full text

Performance of [¹⁸F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA‐AA recommendations for the neuropathologic diagnosis of Alzheimer's disease

Stephen Salloway, José E. Gámez, Upinder Singh et al. · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 2017 · 91 citations · Full text

An Investigation of Levetiracetam in Alzheimer’s Disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept study

Arjune Sen, Mary Akinola, Xin You Tai et al. · Trials · 2021 · 33 citations · Full text

Safety, tolerability, and efficacy outcomes of the Investigation of Levetiracetam in Alzheimer's disease (ILiAD) study: a pilot, double‐blind placebo‐controlled crossover trial

Arjune Sen, Sofia Toniolo, Xin You Tai et al. · Epilepsia Open · 2024 · 11 citations · Full text